Use of bisphosphonates in the prevention of bone loss and fractures
- 1 November 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (5) , S42-S46
- https://doi.org/10.1016/0002-9343(91)90246-t
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A New Option for Treating OsteoporosisNew England Journal of Medicine, 1990
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- PREVENTION OF POSTMENOPAUSAL BONE LOSS BY TILUDRONATEThe Lancet, 1989
- Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humansMetabolism, 1989
- Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APDBone and Mineral, 1989
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- Age-related changes in vertebral trabecular bone architecture—assessed by a new methodBone, 1988
- Variations in strength of vertebrae with age and their relation to osteoporosisCalcified Tissue International, 1967